Witold B. Rybka

Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti–T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease–Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation

Robert J. Soiffer, Haesook T. Kim, Joseph P. McGuirk et al. · Journal of Clinical Oncology · 2017 · 318 citations · Full text

Life Sciences, Hematology, Immunology +16

Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation

Paulo Fontes, A S Rao, P. B. Carroll et al. · The Lancet · 1994 · 309 citations

Medicine, Hematology, Surgery +16

T-Cell Immunoglobulin and ITIM Domain (TIGIT) Associates with CD8+ T-Cell Exhaustion and Poor Clinical Outcome in AML Patients

Yaxian Kong, Liuluan Zhu, Todd D. Schell et al. · Clinical Cancer Research · 2016 · 293 citations

Life Sciences, Hematology, Immunology +17

VISTA is highly expressed on MDSCs and mediates an inhibition of T cell response in patients with AML

Liru Wang, Bei Jia, David F. Claxton et al. · OncoImmunology · 2018 · 176 citations · Full text

Medicine, Immunology, Oncology +17

PD-1hiTIM-3+ T cells associate with and predict leukemia relapse in AML patients post allogeneic stem cell transplantation

Yaxian Kong, J Zhang, David F. Claxton et al. · Blood Cancer Journal · 2015 · 146 citations · Full text

Life Sciences, Hematology, Immunology +17